The 2022 PDA Pharmaceutical Microbiology Conference is an in-person event that will be held on 10-12 October 2022 in Washington, DC.
今年的PDA药品微生物学会议是一场线下活动，将于2022年10月10至12日在美国华盛顿特区举行。
This conference continues the ongoing tradition of addressing the opportunities and challenges, most relevant, to the future of microbiology in today’s global market. Join new and seasoned professionals from all facets of the field, including global industry, academia, and regulatory authorities, to share insights on how to best prepare for the future through the sharing of best practices, development of standards, and integration of innovative technologies, such as:
Ø how to best use non-compendial methods for microbial testing of new products,
Ø how to overcome challenges with aseptic processing
Ø what might be in store for the effective use of risk assessment and mitigation in product manufacturing, environmental monitoring, and microbial control
Ø science of biotech microbiology and its impact on the industry in a dynamic fast-paced global manufacturing environment
本次会议延续了当前的传统，探讨当今全球市场中与微生物学未来最相关的机遇和挑战。与来自该领域各个方面（包括全球工业、学术界和监管机构）的新老专业人士一起，通过分享最佳实践、制定标准和整合创新技术，为未来做好最好的准备，共同分享见解，例如:
Ø 如何最好地使用非药典方法对新产品进行微生物检测
Ø 如何克服无菌加工方面的挑战
Ø 在产品生产、环境监测和微生物控制中，有效使用风险评估和缓解措施可能会出现哪些情况
Ø 在动态的快节奏的全球制造环境中，微生物技术的科学性及其对行业的影响
The Conference will also highlight the following hot topics:
· Novel biotechnology processes, including cell and gene therapies
· Globalization of aseptic processing
· Common microbial deficiencies in regulatory filings and inspections
· Contamination control case studies
· Innovative technologies, products, and processes
· Learned lessons in a post COVID world-perspective from industry and regulators
会议还将重点讨论以下热点话题:
· 新型生物技术工艺，包括细胞和基因疗法
· 无菌加工的全球化
· 监管备案和检查中常见的微生物缺陷
· 污染控制案例研究
· 创新技术、产品和流程
· 从行业和监管机构疫情后的世界观中吸取教训
Come join MICRONVIEW at booth No. 305 to show how effective contamination control can improve your business and to discuss our ability assist your facility needs.
我们诚邀您来到MICRONVIEW 305号展位，与我们探讨如何有效的控制污染来改善您的生产环境，实现更快的放行或采取及时的纠正措施。
Day two of the sold out 2022 PDA Rapid Microbiological Methods Workshop begins with a session on real-time bio-fluorescent detection of microorganisms. This section is focused on bio-fluorescent particle counting (BFPC) systems, an alternative rapid microbiological method capable of continuously monitoring microorganisms in air or water environments.
Allison Scott, Senior Principal Scientist at MicronView, and Caroline Dreyer, Senior Specialist at Novo Nordisk, will be presenting on an industry working group collaboration and the benefits and challenges associated with the implementation of a bio-fluorescent particle counter (BFPC). The first portion of the talk introduces the Modern Microbial Methods (M3) Collaboration and work that this group is undertaking to support modern microbial method use and implementation within industry. Background on BFPC systems for air and water monitoring will be provided, followed by the benefits and challenges encountered by Novo Nordisk when implementing a BFPC system in an isolator. This includes work to validate an air based BFPC system and regulatory perspective on the BFPC technology, as experienced by Novo Nordisk.
2022 PDA快速微生物方法研讨会的第二天，主题为实时生物荧光检测的会议将主要介绍生物荧光粒子计数（BFPC）系统，一种能够连续监测空气或水环境中微生物的快速微生物测定替代方法。
MicronView首席研究员Allison Scott将与诺和诺德高级专家Caroline Dreyer合作演讲。内容主要包括现代微生物方法（M3）和行业工作组织为推行此方法在行业内的使用和实施所开展的相关工作。演讲涵盖了基于BFPC系统的气体和水监测的应用、诺和诺德在隔离器中使用BFPC系统的好处和遇到的挑战、基于BFPC系统的相关气体验证工作以及在BFPC技术方面的监管，正如诺和诺德公司所经历的那样。
